Myocardial Infarction Suppliers & Manufacturers

tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...

We are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses ...

Marizyme Inc. is a multi-technology Life Science company engaged in the research, manufacture and commercialization of medical devices, diagnostics and first-in class products to address unmet clinical needs. Marizyme’s product pipeline is derived ...

Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases. Vaiomer challenges the frontiers of microbiome research by ...